Obesity is a leading cause of hypertension (ie, high blood pressure [BP]). While
hypertension can be managed with antihypertensive medication, substantial weight loss can …

Metabolic syndrome (MS) is defined as the constellation of obesity, insulin resistance, high
serum triglycerides, low high-density lipoprotein cholesterol, and high blood pressure. It …

Abstract Introduction and Objective Metabolic syndrome (MetS) represents a group of
metabolic abnormalities. It is currently a pandemic, and its prevalence is on the rise. MetS …

Introduction Obesity and overweight are becoming progressively more prevalent worldwide
and are independently associated with a significant increase in the risk of cardiovascular …

Context Weight loss failure is a widely recognized occurrence following Roux-en-Y gastric
bypass. Objectives This study aims to identify predictors associated with weight loss failure …

Background The occurrence of gallstones following Roux-en-Y gastric bypass (RYGB) has
been extensively reported. As RYGB promotes improvement in insulin resistance (IR), which …

Bile acids are the end product of cholesterol metabolism in mammals known for their role in
nutrient absorption. Bile acids are amphipathic steroids, acting as physiological surfactants …

Introduction: Bariatric surgery has become the gold standard treatment for morbid obesity,
but there is no consensus regarding its safety and efficacy among individuals with chronic …

The obesity epidemic continues to escalate each year in the United States more than
anywhere else in the world. The existing pharmaceutical and other nonsurgical treatments …

Objective Bariatric surgery is an empirically supported treatment for severe obesity;
however, it does not directly target underlying behavioural and psychological factors that …